PLCε mediated sustained signaling pathways

Advances in Biological Regulation

Volumn 57, Issue , 2015, Pages 17-23

  Dusaban, Stephanie S ^a,b   Brown, Joan Heller ^a  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diacylglycerol (DAG); G protein coupled receptors (GPCRs); Golgi; Inositol 1,4,5 trisphosphate (IP3); Phosphatidylinositol4,5 bisphosphate (PIP2); Phospholipase C (PLC ); Protein kinase D(PKD); Rap1; Ras; RhoA

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C EPSILON; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN; TELOMERE BINDING PROTEIN; TERF2IP PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHATIDYLINOSITOLS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; REPERFUSION INJURY; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS;

EID: 84920767942     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2014.09.014     Document Type: Review

References (34)

1. Bai Y., Edamatsu H., Maeda S., Saito H., Suzuki N., Satoh T., et al. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res 2004, 64:8808-8810.
2. Bunney T.D., Katan M. Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol 2006, 16:640-648.
3. Chan J.J., Katan M. PLCvarepsilon and the RASSF family in tumour suppression and other functions. Adv Biol Regul 2013, 53:258-279.
4. Citro S., Malik S., Oestreich E.A., Radeff-Huang J., Kelley G.G., Smrcka A.V., et al. Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation. Proc Natl Acad Sci U. S. A 2007, 104:15543-15548.
5. Dusaban S.S., Purcell N.H., Rockenstein E., Masliah E., Cho M.K., Smrcka A.V., et al. Phospholipase C{varepsilon} links G protein-coupled receptor activation to inflammatory astrocytic responses. Proc Natl Acad Sci U. S. A 2013, 110:3609-3614.
6. Hains M.D., Wing M.R., Maddileti S., Siderovski D.P., Harden T.K. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors. Mol Pharmacol 2006, 69:2068-2075.
7. Jin T.G., Satoh T., Liao Y., Song C., Gao X., Kariya K., et al. Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling. JBiol Chem 2001, 276:30301-30307.
8. Kelley G.G., Kaproth-Joslin K.A., Reks S.E., Smrcka A.V., Wojcikiewicz R.J. G-protein-coupled receptor agonists activate endogenous phospholipase Cepsilon and phospholipase Cbeta3 in a temporally distinct manner. JBiol Chem 2006, 281:2639-2648.
9. Kelley G.G., Reks S.E., Ondrako J.M., Smrcka A.V. Phospholipase C(epsilon): a novel Ras effector. EMBO J 2001, 20:743-754.
10. Kelley G.G., Reks S.E., Smrcka A.V. Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. Biochem J 2004, 378:129-139.
11. Li M., Edamatsu H., Kitazawa R., Kitazawa S., Kataoka T. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. Carcinogenesis 2009, 30:1424-1432.
12. Lopez I., Mak E.C., Ding J., Hamm H.E., Lomasney J.W. Anovel bifunctional phospholipase c that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway. JBiol Chem 2001, 276:2758-2765.
13. Martins M., McCarthy A., Baxendale R., Guichard S., Magno L., Kessaris N., et al. Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers. Proc Natl Acad Sci U. S. A 2014, 111:4239-4244.
14. Means C.K., Xiao C.Y., Li Z., Zhang T., Omens J.H., Ishii I., et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against invivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007, 292:H2944-H2951.
15. Newton A.C. Lipid activation of protein kinases. JLipid Res 2009, 50(Suppl.):S266-S271.
16. Oestreich E.A., Wang H., Malik S., Kaproth-Joslin K.A., Blaxall B.C., Kelley G.G., et al. Epac-mediated activation of phospholipase C(epsilon) plays a critical role in beta-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. JBiol Chem 2007, 282:5488-5495.
17. Oka M., Edamatsu H., Kunisada M., Hu L., Takenaka N., Dien S., et al. Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cepsilon-knockout mice is associated with decreased cell death. Carcinogenesis 2010, 31:1897-1902.
18. Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease. Physiol (Bethesda) 2011, 26:23-33.
19. Schmidt M., Evellin S., Weernink P.A., von Dorp F., Rehmann H., Lomasney J.W., et al. Anew phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol 2001, 3:1020-1024.
20. Shibatohge M., Kariya K., Liao Y., Hu C.D., Watari Y., Goshima M., et al. Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras. JBiol Chem 1998, 273:6218-6222.
21. Siehler S. Regulation of RhoGEF proteins by G12/13-coupled receptors. Br J Pharmacol 2009, 158:41-49.
22. Song C., Hu C.D., Masago M., Kariyai K., Yamawaki-Kataoka Y., Shibatohge M., et al. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. JBiol Chem 2001, 276:2752-2757.
23. Song C., Satoh T., Edamatsu H., Wu D., Tadano M., Gao X., et al. Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene 2002, 21:8105-8113.
24. Sternweis P.C., Carter A.M., Chen Z., Danesh S.M., Hsiung Y.F., Singer W.D. Regulation of Rho guanine nucleotide exchange factors by G proteins. Adv Protein Chem 2007, 74:189-228.
25. Suzuki N., Hajicek N., Kozasa T. Regulation and physiological functions of G12/13-mediated signaling pathways. Neurosignals 2009, 17:55-70.
26. Vessey D.A., Li L., Honbo N., Karliner J.S. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol 2009, 297:H1429-H1435.
27. Vessey D.A., Li L., Kelley M., Zhang J., Karliner J.S. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate. JBiochem Mol Toxicol 2008, 22:113-118.
28. Wang Q.J. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 2006, 27:317-323.
29. Wang H., Oestreich E.A., Maekawa N., Bullard T.A., Vikstrom K.L., Dirksen R.T., et al. Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy. Circ Res 2005, 97:1305-1313.
30. Wing M.R., Houston D., Kelley G.G., Der C.J., Siderovski D.P., Harden T.K. Activation of phospholipase C-epsilon by heterotrimeric G protein betagamma-subunits. JBiol Chem 2001, 276:48257-48261.
31. Wing M.R., Snyder J.T., Sondek J., Harden T.K. Direct activation of phospholipase C-epsilon by Rho. JBiol Chem 2003, 278:41253-41258.
32. Xiang S.Y., Ouyang K., Yung B.S., Miyamoto S., Smrcka A.V., Chen J., et al. PLCepsilon, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart. Sci Signal 2013, 6:ra108.
33. Zhang L., Malik S., Kelley G.G., Kapiloff M.S., Smrcka A.V. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes. JBiol Chem 2011, 286:23012-23021.
34. Zhang L., Malik S., Pang J., Wang H., Park K.M., Yule D.I., et al. Phospholipase Cepsilon hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy. Cell 2013, 153:216-227.